Acute canagliflozin treatment protects against in vivo myocardial ischemia–reperfusion injury in non-diabetic male rats and enhances endothelium-dependent vasorelaxation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Acute canagliflozin treatment protects against in vivo myocardial ischemia–reperfusion injury in non-diabetic male rats and enhances endothelium-dependent vasorelaxation ; volume:17 ; number:1 ; day:16 ; month:4 ; year:2019 ; pages:1-14 ; date:12.2019
Journal of translational medicine ; 17, Heft 1 (16.4.2019), 1-14, 12.2019
- Urheber
-
Sayour, Alex Ali
Korkmaz-İçöz, Sevil
Loganathan, Sivakkanan
Ruppert, Mihály
Sayour, Viktor Nabil
Oláh, Attila
Benke, Kálmán
Brune, Maik
Benkő, Rita
Horváth, Eszter Mária
Karck, Matthias
Merkely, Béla
Radovits, Tamás
Szabó, Gábor
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-019-1881-8
- URN
-
urn:nbn:de:101:1-2019051022584129966616
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sayour, Alex Ali
- Korkmaz-İçöz, Sevil
- Loganathan, Sivakkanan
- Ruppert, Mihály
- Sayour, Viktor Nabil
- Oláh, Attila
- Benke, Kálmán
- Brune, Maik
- Benkő, Rita
- Horváth, Eszter Mária
- Karck, Matthias
- Merkely, Béla
- Radovits, Tamás
- Szabó, Gábor
- SpringerLink (Online service)
Ähnliche Objekte (12)
The endothelium: gatekeeper to lung ischemia-reperfusion injury
TREM2 protects against cerebral ischemia/reperfusion injury
Levosimendan protects human hepatocytes from ischemia-reperfusion injury
Levosimendan protects human hepatocytes from ischemia-reperfusion injury
Endothelial prostacyclin protects the kidney from ischemia-reperfusion injury
Empagliflozin protects against renal ischemia/reperfusion injury in mice
Inhibition of cardiomyocyte Sprouty1 protects from cardiac ischemia–reperfusion injury
Cathelicidin-related antimicrobial peptide protects against myocardial ischemia/reperfusion injury
Intermedin protects against myocardial ischemia-reperfusion injury in diabetic rats
Resolvin D2 protects against cerebral ischemia/reperfusion injury in rats
PIAS1 protects against myocardial ischemia-reperfusion injury by stimulating PPARγ SUMOylation
Hydroxysafflor Yellow A protects spinal cords from ischemia/reperfusion injury in rabbits
The endothelium: gatekeeper to lung ischemia-reperfusion injury
TREM2 protects against cerebral ischemia/reperfusion injury
Levosimendan protects human hepatocytes from ischemia-reperfusion injury
Levosimendan protects human hepatocytes from ischemia-reperfusion injury
Endothelial prostacyclin protects the kidney from ischemia-reperfusion injury
Empagliflozin protects against renal ischemia/reperfusion injury in mice
Inhibition of cardiomyocyte Sprouty1 protects from cardiac ischemia–reperfusion injury
Cathelicidin-related antimicrobial peptide protects against myocardial ischemia/reperfusion injury
Intermedin protects against myocardial ischemia-reperfusion injury in diabetic rats
Resolvin D2 protects against cerebral ischemia/reperfusion injury in rats
PIAS1 protects against myocardial ischemia-reperfusion injury by stimulating PPARγ SUMOylation
Hydroxysafflor Yellow A protects spinal cords from ischemia/reperfusion injury in rabbits
The endothelium: gatekeeper to lung ischemia-reperfusion injury
TREM2 protects against cerebral ischemia/reperfusion injury
Levosimendan protects human hepatocytes from ischemia-reperfusion injury
Levosimendan protects human hepatocytes from ischemia-reperfusion injury
Endothelial prostacyclin protects the kidney from ischemia-reperfusion injury
Empagliflozin protects against renal ischemia/reperfusion injury in mice
Inhibition of cardiomyocyte Sprouty1 protects from cardiac ischemia–reperfusion injury
Cathelicidin-related antimicrobial peptide protects against myocardial ischemia/reperfusion injury
Intermedin protects against myocardial ischemia-reperfusion injury in diabetic rats
Resolvin D2 protects against cerebral ischemia/reperfusion injury in rats
PIAS1 protects against myocardial ischemia-reperfusion injury by stimulating PPARγ SUMOylation